| Title |
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
|
|---|---|
| Published in |
Diabetologia, December 2018
|
| DOI | 10.1007/s00125-018-4786-9 |
| Pubmed ID | |
| Authors |
Ana Luisa Perdigoto, Paula Preston-Hurlburt, Pamela Clark, S. Alice Long, Peter S. Linsley, Kristina M. Harris, Steven E. Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, William Hagopian, Alyssa Woodwyk, James Dziura, Kevan C. Herold |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 6 | 25% |
| United States | 3 | 13% |
| Germany | 1 | 4% |
| Malaysia | 1 | 4% |
| Brazil | 1 | 4% |
| Unknown | 12 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 67% |
| Practitioners (doctors, other healthcare professionals) | 4 | 17% |
| Scientists | 3 | 13% |
| Unknown | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 114 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 12% |
| Student > Bachelor | 14 | 12% |
| Student > Ph. D. Student | 8 | 7% |
| Student > Master | 8 | 7% |
| Other | 5 | 4% |
| Other | 15 | 13% |
| Unknown | 50 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 24% |
| Immunology and Microbiology | 11 | 10% |
| Biochemistry, Genetics and Molecular Biology | 7 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 11 | 10% |
| Unknown | 49 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2023.
All research outputs
#1,102,215
of 25,473,687 outputs
Outputs from Diabetologia
#573
of 5,349 outputs
Outputs of similar age
#24,909
of 444,414 outputs
Outputs of similar age from Diabetologia
#14
of 57 outputs
Altmetric has tracked 25,473,687 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,349 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,414 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.